e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Novel mechanisms and targets of molecular pulmonary pathology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients
G. Caramori, P. Casolari, P. Kirkham, J. Marwick, M. Contoli, A. Zanforlin, K. Ito, K. F. Chung, P. J. Barnes, I. M. Adcock, A. Papi (Ferrara, Italy; Horsham, London, United Kingdom)
Source:
Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Session:
Novel mechanisms and targets of molecular pulmonary pathology
Session type:
Thematic Poster Session
Number:
3528
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Caramori, P. Casolari, P. Kirkham, J. Marwick, M. Contoli, A. Zanforlin, K. Ito, K. F. Chung, P. J. Barnes, I. M. Adcock, A. Papi (Ferrara, Italy; Horsham, London, United Kingdom). Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients. Eur Respir J 2008; 32: Suppl. 52, 3528
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Increased expression of heat shock protein 70 in COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Heat shock proteins and FKBP51 expression in sputum cells of COPD patients during formoterol/budesonide/theophylline therapy
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Heat shock protein (HSP) 72 polymorphism in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 52s
Year: 2005
Heat shock protein (HSP) 72 polymorphism in small cell lung cancer (SCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 330s
Year: 2005
Serum heat shock protein 47 levels in patients with drug induced lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Heat shock protein expression in small cell lung cancer (SCLC)
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007
Increased circulating heat shock protein 70 levels in pregnant asthmatics
Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Year: 2010
Heat shock proteins (HSP)-10 and –40 increase in bronchial biopsies of patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Heat shock protein 90 inhibitors block pulmonary fibrosis and dysfunction in HCl-exposed mice.
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017
The potential role of intracellular heat shock protein 70 deficiency in aging and pulmonary fibrosis.
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017
Correlation between extracellular heat shock protein 72 and clinical parameters including exhaled oxygen level in COPD
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Anti-human heat shock protein 60 antibodies and longitudinal change in percent emphysema and lung function: The MESA lung study
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Extracorporeal shock waves increase markers of cellular proliferation in primary bronchial fibroblasts of COPD patients
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
Post-treatment with the heat shock protein 90 (hsp90) inhibitor, AUY-922, reduces lung hsp90 tyrosine (Y) phosphorylation and pulmonary inflammation in LPS-induced acute lung injury (ALI) in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Mycobacterial heat shock proteins in sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008
Heat shock protein: a hot topic in idiopathic pulmonary fibrosis
Source: Eur Respir J , 49 (2) 1602152; DOI: 10.1183/13993003.02152-2016
Year: 2017
RAGE expression in lung tissue of ARDS and septic patients
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020
Spontaneous and mycobacterial heat shock proteins – induced apoptosis of monocytes in sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006
Heat shock protein-90 toward theranostics: a breath of fresh air in idiopathic pulmonary fibrosis
Source: Eur Respir J, 51 (2) 1702612; 10.1183/13993003.02612-2017
Year: 2018
Role of heat shock proteins in the lungs of acute lung injury
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept